Chase Woodward, MD
Orthopaedic Surgery of the Spine · Omaha, NENPI 1154682052
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,606 of the $5,754 with a category attached, or 62.7%. 18 manufacturers reported payments, led by Globus Medical at 57.1% of the total.
Across 67 payments — averaging $85.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$3K
- Conetic Solutions, Inc.$867
- Medtronic$561
- Arthrex$288
- Cerapedics Inc.$230
- Orthofix Medical, Inc.$150
- plus $372 from 12 others
What the payments were for
- Travel & lodging$3,60663%
- Food & beverage$2,14837%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 24 | $3,285 |
| Conetic Solutions, Inc. | 7 | $867 |
| Medtronic | 9 | $561 |
| Arthrex | 3 | $288 |
| Cerapedics Inc. | 7 | $230 |
| Orthofix Medical, Inc. | 2 | $150 |
| Aesculap Implant Systems, LLC | 1 | $124 |
| Augmedics Inc. | 1 | $45 |
| Si-bone, Inc. | 2 | $29 |
| Mallinckrodt Enterprises LLC | 2 | $26 |
| Centinel Spine, LLC | 1 | $24 |
| Spineology Inc. | 1 | $21 |
| Surgalign Spine Technologies, Inc. | 2 | $21 |
| Amgen | 1 | $21 |
| Boston Scientific | 1 | $17 |
| Abbott | 1 | $16 |
| Misonix Inc | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XLIF$1,871
- RISE-L$545
- UNID_PASS$136
- ACTIVL ARTIFICIAL DISC$124
- LessRay$111
- Excelsius - GPS$104
How this compares
Too few orthopaedic surgery of the spine providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 39 | $732 |
| Gabapentin | 69 | $614 |
| Methylprednisolone | 43 | $332 |
| Diclofenac Sodium | 25 | $274 |
| Cyclobenzaprine Hcl | 21 | $139 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Omaha
- Travis BaileyOmaha$7K
- James GillOmaha$4K
- Timothy BurdOmaha$4K
- John McClellanOmaha$4K
- Adam SchellOmaha$3K
- Eric PhillipsOmaha$2K
- Michael LongleyOmaha$1K
- Johnathan FullerOmaha$470
- Geoffrey McCullenLincoln$39K
- David BenavidesKearney$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.